Reported Earlier: Vera Therapeutics To Present Phase 3 Atacicept Data For IgAN In Featured Late-Breaking Session At ASN Kidney Week 2025
Author: Benzinga Newsdesk | October 17, 2025 10:31am
Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that data from the ORIGIN Phase 3 clinical trial of atacicept for the treatment of IgA nephropathy (IgAN) will be delivered as a featured late-breaking oral presentation during the opening plenary session of the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas, being held November 6 to 9. In addition, two informational posters will describe the ORIGIN Extend and PIONEER trials of atacicept in IgAN and other autoimmune mediated glomerular diseases.
ASN Kidney Week 2025 Presentation Details
Title:
ORIGIN 3: A Phase 3 Trial of Atacicept in IgAN
Presenting Author:
Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Abstract Number:
TH-OR083
Session Title:
Opening Plenary: Featured High-Impact Clinical Trials
Session Date, Time:
Thursday, November 6, 2025 from 9:02 AM to 9:14 AM CST
Location:
Hall A, Convention Center
Title:
ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgAN
Presenting Author:
Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Poster Board Number:
INFO12-TH
Session Date, Time:
Thursday, November 6, 2025 from 10:00 AM to 12:00 PM CST
Location:
Exhibit Hall, Convention Center
Title:
PIONEER: A Basket Trial of Atacicept in Autoimmune Mediated Glomerular Disease
Presenting Author:
Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Poster Board Number:
INFO13-TH
Session Date, Time:
Thursday, November 6, 2025 from 10:00 AM to 12:00 PM CST
